ClinicalTrials.Veeva

Menu

Left Atrial FLUTter: a Comparison of Ablation Guided by High-density MApping and Empirical LINEar Ablation. (FLUTMALINE)

M

Madrid Health Service

Status

Enrolling

Conditions

Arrhythmias, Cardiac

Treatments

Other: Radiofrecuency ablation

Study type

Interventional

Funder types

Other

Identifiers

NCT05063032
5825 v 3.0, 3030th March 2021

Details and patient eligibility

About

Unicenter, 1:1 randomized, open-labelled clinical trial comparing left atrial flutter ablation using high density mapping or strict lineal ablation. Main outcome: arrhythmia recurrences over 1 year follow-up with daily 1-lead 30 seconds ECG samples.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Left atrial flutter1 inducible during electrophysiological evaluation.

  • Clinical indication for ablation: a) symptoms (palpitations, dizziness, syncope, breathlessness, derangement, heart failure), tachymiopathy, b) poor heart rate control, or c) recurrence after electrical cardioversion or failure of one antiarrhythmic drug.

  • Informed consent.

    1. Patients will be enrolled if LAFL is clinically suspected but finally randomized if this mechanism is established by electrophysiologic evaluation according to the criteria stated above.

Exclusion criteria

  • Previous ablation of LAFL.
  • Previous linear ablation in the LA except for pulmonary vein isolation.
  • Absolute contraindication for oral anticoagulation.
  • Stroke or acute coronary syndrome less than 3 months before ablation.
  • Complex congenital heart disease.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

High-density mapping guided ablation
Experimental group
Description:
High-density map and return-cycles map in order to localize the protected isthmus with precision for focal/minimal ablation.
Treatment:
Other: Radiofrecuency ablation
Empirical linear ablation
Active Comparator group
Description:
Empirical predefined set of linear ablation.
Treatment:
Other: Radiofrecuency ablation

Trial contacts and locations

1

Loading...

Central trial contact

Sergio C Castrejón, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems